---
schema_version: "secwatch.filing_event.v1"
accession: "0001472375-21-000133"
form_type: "8-K"
ticker: "RGPX"
cik: "0001357878"
company_name: "REGENEREX PHARMA, INC."
filed_at: "2021-11-18T23:59:59+00:00"
generated_at: "2026-06-28T06:55:17.651841+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Peptide Technologies acquires wound healing IP for 150M shares and $10M deferred cash

## Summary
- Acquired Wound Healing Technology Platform from Gregory P. Pilant and Deborah L. Pilant for 150M restricted common shares and $10M deferred cash.
- Cash payment of $10M to be funded from future revenue or investment, due within 60 months, with no interest.
- Closing deadline set for November 25, 2021 (within 10 days of signing on November 15, 2021).
- Technology platform includes drug candidates and biological solutions for chronic wound care in humans.

## SEC filing metadata
- accession: 0001472375-21-000133
- form_type: 8-K
- ticker: RGPX
- cik: 0001357878
- company_name: REGENEREX PHARMA, INC.
- filed_at: 2021-11-18T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000133/0001472375-21-000133-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1357878/000147237521000133/ixform8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001472375-21-000133
- JSON: https://secwatch.observer/filing/0001472375-21-000133.json
- Plain text: https://secwatch.observer/filing/0001472375-21-000133.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.